Sakai Takehiko相关文献与解析，生知库 | 链接生命科学的每一步

Kokubu, Yumi; Osako, Tomo; Sakai, Takehiko; Tomita, Yui; Kato, Chieko; Maruoka, Yuri; Akiya, Masashi; Takahata, Chikako; Ueno, Takayuki; Matsueda, Kiyoshi

淋巴瘤

发表日期：2026

文献求助收藏

Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trial

新辅助化疗治疗HER2阳性早期乳腺癌以期避免手术的临床完全缓解及其预测因素：JCOG1806试验的探索性分析

期刊:International Journal of Clinical Oncology

影响因子:2.8

doi:10.1007/s10147-026-02967-7

Shigematsu, Hideo; Fujisawa, Tomomi; Hara, Fumikata; Iwata, Hiroji; Ishiba, Toshiyuki; Ozaki, Yukinori; Sakai, Takehiko; Sagara, Yasuaki; Shimomura, Akihiko; Sudo, Kazuki; Terata, Kaori; Naito, Yoichi; Nozawa, Kazuki; Sasaki, Keita; Mitome, Noriko; Sadachi, Ryo; Shibata, Taro; Shien, Tadahiko

Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer.

腋窝脂肪组织来源的淋巴内皮细胞表现出独特的转录组特征，反映了乳腺癌的淋巴侵袭状态

期刊:Breast Cancer Research

影响因子:5.6

doi:10.1186/s13058-025-02067-w

Iesato Asumi, Suzuka Jun, Otsuji Kazutaka, Osako Tomo, Yamashita Nami, Inoue Yuka, Maeda Tetsuyo, Uehiro Natsue, Yoshida Kazuyo, Takahashi Yoko, Kumegawa Kohei, Saeki Sumito, Yang Liying, Tsuchiya Ai, Sakiyama Kana, Tanaka Miwa, Sakai Takehiko, Ohno Shinji, Noda Tetsuo, Ueno Takayuki, Maruyama Reo

Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity

根据国际指南对乳腺癌治疗功能评估量表（FACT-B+4）进行日语翻译：语言有效性验证

期刊:Breast Cancer

影响因子:2.9

doi:10.1007/s12282-025-01701-x

Tsukioki, Takahiro; Takata, Nozomu; Dennis, Saya R; Terata, Kaori; Sagara, Yasuaki; Sakai, Takehiko; Takayama, Shin; Kitagawa, Dai; Kikawa, Yuichiro; Takahashi, Yuko; Iwatani, Tsuguo; Hara, Fumikata; Fujisawa, Tomomi; Shien, Tadahiko

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study

开发和验证一种结合真实世界数据和荟萃分析证据的同侧乳腺肿瘤复发风险评估工具：一项回顾性多中心队列研究

期刊:JCO Clinical Cancer Informatics

影响因子:2.8

doi:10.1200/CCI-25-00182

Sagara, Yasuaki; Yoshida, Atsushi; Kimura, Yuri; Ishitobi, Makoto; Ono, Yuka; Takahashi, Yuko; Tsukioki, Takahiro; Takada, Koji; Ito, Yuri; Osako, Tomo; Sakai, Takehiko

Design Paper: A Prospective, Multicenter, Single-arm, Phase II Trial of Tailored Axillary Surgery in Patients with Clinically Node-positive Breast Cancer in the Upfront Surgery Setting

设计论文：一项前瞻性、多中心、单臂 II 期临床试验，旨在研究在初始手术阶段对临床淋巴结阳性乳腺癌患者进行个体化腋窝手术的效果。

期刊:JMA Journal

影响因子:1.8

doi:10.31662/jmaj.2024-0187

Sagara, Yasuaki; Terata, Kaori; Sakai, Takehiko; Takayama, Shin; Kitagawa, Dai; Iwatani, Tsuguo; Tsukioki, Takahiro; Ogita, Mami; Sanuki, Naoko; Yoshida, Masayuki; Tsuda, Hitoshi; Yamamoto, Seiichiro; Iwata, Hiroji; Shien, Tadahiko

Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

更正：日本乳腺癌学会《乳腺癌临床实践指南》（2022版）：与2018版相比的变更以及关于乳腺癌治疗的一般性声明

期刊:Breast Cancer

影响因子:2.9

doi:10.1007/s12282-024-01589-z

Yamamoto, Yutaka; Yamauchi, Chikako; Toyama, Tatsuya; Nagai, Shigenori; Sakai, Takehiko; Kutomi, Goro; Yoshimura, Michio; Kawai, Masaaki; Ohtani, Shoichiro; Kubota, Kazunori; Nakashima, Kazutaka; Honma, Naoko; Yoshida, Masayuki; Tokunaga, Eriko; Taira, Naruto; Iwata, Hiroji; Saji, Shigehira

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

日本乳腺癌学会乳腺癌临床实践指南（2022版）：与2018版相比的变更及关于乳腺癌治疗的一般性声明

期刊:Breast Cancer

影响因子:2.9

doi:10.1007/s12282-024-01566-6

Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy

一项针对接受新辅助内分泌治疗（联合或不联合辅助化疗）的雌激素受体阳性早期乳腺癌患者的长期预后III期研究

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-023-06874-7

Iwata, Hiroji; Yamamoto, Yutaka; Sakai, Takehiko; Hasegawa, Yoshie; Nakamura, Rikiya; Akabane, Hiromitsu; Ohtani, Shoichiro; Kashiwaba, Masahiro; Taira, Naruto; Toyama, Tatsuya; Fujisawa, Tomomi; Masuda, Norikazu; Shibahara, Yukiko; Sasano, Hironobu; Yamaguchi, Takuhiro

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer

中性粒细胞与淋巴细胞比值在寡转移性乳腺癌中的临床意义

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-022-06726-w

Inoue, Yuka; Fujishima, Makoto; Ono, Makiko; Masuda, Jun; Ozaki, Yukinori; Maeda, Tetsuyo; Uehiro, Natsue; Takahashi, Yoko; Kobayashi, Takayuki; Sakai, Takehiko; Osako, Tomo; Ueno, Takayuki; Ohno, Shinji

Causes of varied internal echo patterns in ultrasound imaging of breast lymphoma

乳腺淋巴瘤超声成像中不同内部回声模式的原因

Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trial

新辅助化疗治疗HER2阳性早期乳腺癌以期避免手术的临床完全缓解及其预测因素：JCOG1806试验的探索性分析

Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer.

腋窝脂肪组织来源的淋巴内皮细胞表现出独特的转录组特征，反映了乳腺癌的淋巴侵袭状态

Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity

根据国际指南对乳腺癌治疗功能评估量表（FACT-B+4）进行日语翻译：语言有效性验证

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study

开发和验证一种结合真实世界数据和荟萃分析证据的同侧乳腺肿瘤复发风险评估工具：一项回顾性多中心队列研究

Design Paper: A Prospective, Multicenter, Single-arm, Phase II Trial of Tailored Axillary Surgery in Patients with Clinically Node-positive Breast Cancer in the Upfront Surgery Setting

设计论文：一项前瞻性、多中心、单臂 II 期临床试验，旨在研究在初始手术阶段对临床淋巴结阳性乳腺癌患者进行个体化腋窝手术的效果。

Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

更正：日本乳腺癌学会《乳腺癌临床实践指南》（2022版）：与2018版相比的变更以及关于乳腺癌治疗的一般性声明

The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

日本乳腺癌学会乳腺癌临床实践指南（2022版）：与2018版相比的变更及关于乳腺癌治疗的一般性声明

Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy

一项针对接受新辅助内分泌治疗（联合或不联合辅助化疗）的雌激素受体阳性早期乳腺癌患者的长期预后III期研究

Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer

中性粒细胞与淋巴细胞比值在寡转移性乳腺癌中的临床意义